GH Research (GHRS) Consolidated Net Income (2020 - 2025)

GH Research (GHRS) recorded quarterly Consolidated Net Income of -$14.1 million in Q4 2025, down 0.83% quarter-over-quarter from -$14.0 million in Q3 2025, and down 60.61% on a YoY basis from -$35.9 million in Q4 2024.

GH Research (GHRS) Consolidated Net Income (2020 - 2025) Analysis & Trends

GH Research's Consolidated Net Income history runs 6 years deep, the most recent figure standing at -$14.1 million for Q4 2025.

  • In Q4 2025, Consolidated Net Income fell 60.61% year-over-year to -$14.1 million; the TTM figure through Dec 2025 stood at -$48.3 million (down 23.86% YoY), while the FY2025 annual figure was -$48.3 million, down 23.86% from the prior year.
  • Consolidated Net Income was -$14.1 million for Q4 2025 at GH Research, down from -$14.0 million in the prior quarter.
  • In the past five years, Consolidated Net Income ranged from a high of $334000.0 in Q2 2022 to a low of -$16.6 million in Q4 2022.
  • Historically, Consolidated Net Income has averaged -$7.7 million across 5 years, with a median of -$8.3 million in 2023.
  • The sharpest annual moves came in 2021 and 2022: Consolidated Net Income tumbled 2961.67% in 2021, then soared 115.72% in 2022.
  • A 5-year view of Consolidated Net Income shows it stood at -$4.1 million in 2021, then tumbled by 305.43% to -$16.6 million in 2022, then surged by 32.04% to -$11.3 million in 2023, then climbed by 21.91% to -$8.8 million in 2024, then sank by 60.61% to -$14.1 million in 2025.
  • The last three Consolidated Net Income figures came in at -$14.1 million (Q4 2025), -$14.0 million (Q3 2025), and -$9.3 million (Q2 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Consol Net Inc. (Qtr)
1 Alterity Therapeutics 723,416.35 Bn 723,416.32 Bn - -
2 Belite Bio 57,340.00 Bn 57,340.00 Bn - -26.94 Mn
3 Quantum Biopharma 19,125.08 Bn 19,125.08 Bn - -2.97 Mn
4 Legend Biotech 3,262.00 Bn 3,261.71 Bn 242.10 Mn 30.80 Mn
5 Akari Therapeutics 1,789.67 Bn 1,789.67 Bn - -14.46 Mn
6 Evaxion A 1,480.39 Bn 1,480.37 Bn - -3.40 Mn
7 Psyence Biomedical 241.78 Bn 241.78 Bn - -1.50 Mn
8 Vertex Pharmaceuticals 113.54 Bn 106.29 Bn 2.59 Bn 1.03 Bn
9 Abivax 94.26 Bn 94.26 Bn - -56.48 Mn
10 GH Research 9.73 Bn 9.63 Bn - -14.14 Mn

Historic Data

Download Data
DateValue
Dec 31, 2025 -14.14 Mn
Sep 30, 2025 -14.02 Mn
Jun 30, 2025 -9.29 Mn
Mar 31, 2025 -10.81 Mn
Dec 31, 2024 -8.80 Mn
Sep 30, 2024 -12.11 Mn
Jun 30, 2024 -10.38 Mn
Mar 31, 2024 -7.67 Mn
Dec 31, 2023 -11.27 Mn
Sep 30, 2023 -5.65 Mn
Jun 30, 2023 -7.73 Mn
Mar 31, 2023 -10.94 Mn
Dec 31, 2022 -16.59 Mn
Sep 30, 2022 -441,000.00
Jun 30, 2022 334,000.00
Mar 31, 2022 -5.76 Mn
Dec 31, 2021 -4.09 Mn
Sep 30, 2021 -1.84 Mn
Jun 30, 2021 -2.13 Mn
Mar 31, 2021 -1.15 Mn